Rinvoq: payments to doctors
Payments that named Rinvoq as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $86.6M
- Providers
- 53,868
- Transactions
- 1,076,889
- Average per transaction
- $80
The per-transaction average — $80 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 53,868 providers the average total is $1,608, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AbbVie | $86,640,336 | 100.0% |